Works matching IS 10837159 AND DT 2017 AND VI 22 AND IP 3

Results: 16

FDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti-Angiogenic Therapy and Exploratory Predictive Biomarker Analysis.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 311, doi. 10.1634/theoncologist.2016-0476

By:

Xu, James Xunhai;
Maher, V. Ellen;
Zhang, Lijun;
Tang, Shenghui;
Sridhara, Rajeshwari;
Ibrahim, Amna;
Kim, Geoffrey;
Pazdur, Richard

Publication type:

Article

Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 255, doi. 10.1634/theoncologist.2016-0279

By:

Vanden Borre, Pierre;
Schrock, Alexa B.;
Anderson, Peter M.;
Morris, John C.;
Heilmann, Andreas M.;
Holmes, Oliver;
Wang, Kai;
Johnson, Adrienne;
Waguespack, Steven G.;
Ou, Sai‐Hong Ignatius;
Khan, Saad;
Fung, Kar‐Ming;
Stephens, Philip J.;
Erlich, Rachel L.;
Miller, Vincent A.;
Ross, Jeffrey S.;
Ali, Siraj M.

Publication type:

Article

Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 335, doi. 10.1634/theoncologist.2016-0276

By:

Vallet‐Regí, María;
Manzano, Miguel;
Rodriguez‐Mañas, Leocadio;
Checa López, Marta;
Aapro, Matti;
Balducci, Lodovico;
Barbacid, Mariano;
Guise, Theresa A.;
Mena, Alfredo Carrato;
Ortiz Romero, Pablo L.;
Orellana, Manuel Ramírez;
Mañas, Leocadio Rodríguez

Publication type:

Article

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 245, doi. 10.1634/theoncologist.2016-0265

By:

Vahdat, Linda T.;
Layman, Rachel;
Yardley, Denise A.;
Gradishar, William;
Salkeni, Mohamad A.;
Joy, Anil Abraham;
Garcia, Agustin A.;
Ward, Patrick;
Khatcheressian, James;
Sparano, Joseph;
Rodriguez, Gladys;
Tang, Shande;
Gao, Ling;
Dalal, Rita P.;
Kauh, John;
Miller, Kathy

Publication type:

Article

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 343, doi. 10.1634/theoncologist.2016-0298

By:

Sultan, Ahmed;
Hanna, Glenn J.;
Margalit, Danielle N.;
Chau, Nicole;
Goguen, Laura A.;
Marty, Francisco M.;
Rabinowits, Guilherme;
Schoenfeld, Jonathan D.;
Sonis, Stephen T.;
Thomas, Tom;
Tishler, Roy B.;
Treister, Nathaniel S.;
Villa, Alessandro;
Woo, Sook‐Bin;
Haddad, Robert;
Mawardi, Hani

Publication type:

Article

Multidisciplinary Management of Breast Cancer During Pregnancy.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 324, doi. 10.1634/theoncologist.2016-0208

By:

Shachar, Shlomit Strulov;
Gallagher, Kristalyn;
McGuire, Kandace;
Zagar, Timothy M.;
Faso, Aimee;
Muss, Hyman B.;
Sweeting, Raeshall;
Anders, Carey K.

Publication type:

Article

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRASMutant Colorectal Adenocarcinoma.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 243, doi. 10.1634/theoncologist.2016-0479

By:

Hecht, J. Randolph;
Benson, Al B.;
Vyushkov, Dmitry;
Yang, Yingsi;
Bendell, Johanna;
Verma, Udit

Publication type:

Article

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 286, doi. 10.1634/theoncologist.2016-0078

By:

de Velasco, Guillermo;
Culhane, Aedín C.;
Fay, André P.;
Hakimi, A. Ari;
Voss, Martin H.;
Tannir, Nizar M.;
Tamboli, Pheroze;
Appleman, Leonard J.;
Bellmunt, Joaquim;
Kimryn Rathmell, W.;
Albiges, Laurence;
Hsieh, James J.;
Heng, Daniel Y. C.;
Signoretti, Sabina;
Choueiri, Toni K.

Publication type:

Article

Gastroenteropancreatic Neuroendocrine Carcinomas: The NET G3 Subcategory Is a Reality.

Published in:

2017

By:

Fazio, Nicola;
Milione, Massimo

Publication type:

Letter to the Editor

The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 272, doi. 10.1634/theoncologist.2016-0305

By:

Michael, Michael;
Garcia‐Carbonero, Rocio;
Weber, Matthias M.;
Lombard‐Bohas, Catherine;
Toumpanakis, Christos;
Hicks, Rodney J.

Publication type:

Article

Efficacy and Safety of FOLFIRI Regimen in Elderly Patients with Metastatic Colorectal or Gastric Cancer.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 293, doi. 10.1634/theoncologist.2016-0166

By:

Kim, Ji‐Won;
Lee, Keun‐Wook;
Kim, Kyu‐Pyo;
Lee, Ju Hyun;
Hong, Yong Sang;
Kim, Jeong‐Eun;
Kim, Sun Young;
Park, Sook Ryun;
Nam, Byung‐Ho;
Cho, Sang‐Hee;
Chung, Ik‐Joo;
Park, Young Suk;
Oh, Ho‐Suk;
Lee, Myung‐Ah;
Kang, Hye Jin;
Park, Young Iee;
Song, Eun‐Kee;
Han, Hye Sook;
Lee, Kyu Taeg;
Shin, Dong Bok

Publication type:

Article

Survival Gains from First-Line Systemic Therapy in Metastatic Non-Small Cell Lung Cancer in the U.S., 1990-2015: Progress and Opportunities.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 304, doi. 10.1634/theoncologist.2016-0253

By:

Roth, Joshua A.;
Goulart, Bernardo H. L.;
Ravelo, Arliene;
Kolkey, Holli;
Ramsey, Scott D.

Publication type:

Article

Early Palliative Care Reduces End-of-Life Intensive Care Unit (ICU) Use but Not ICU Course in Patients with Advanced Cancer.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 318, doi. 10.1634/theoncologist.2016-0227

By:

Romano, Andrew M.;
Gade, Kristine E.;
Nielsen, Gradon;
Havard, Robert;
Harrison, James H.;
Barclay, Josh;
Stukenborg, George J.;
Read, Paul W.;
Blackhall, Leslie J.;
Dillon, Patrick M.

Publication type:

Article

Population-Level Differences in Rectal Cancer Survival in Uninsured Patients Are Partially Explained by Differences in Treatment.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 351, doi. 10.1634/theoncologist.2016-0274

By:

Pulte, Dianne;
Jansen, Lina;
Brenner, Hermann

Publication type:

Article

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 241, doi. 10.1634/theoncologist.2017-0024

By:

Benson, Al B.;
Wainberg, Zev A.;
Hecht, J. Randolph;
Vyushkov, Dmitry;
Dong, Hua;
Bendell, Johanna;
Kudrik, Fred

Publication type:

Article

A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with orWithout the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 264, doi. 10.1634/theoncologist.2016-0223

By:

Bendell, Johanna C.;
Hochster, Howard;
Hart, Lowell L.;
Firdaus, Irfan;
Mace, Joseph R.;
McFarlane, Joshua J.;
Kozloff, Mark;
Catenacci, Daniel;
Hsu, Jessie J.;
Hack, Stephen P.;
Shames, David S.;
Phan, See‐Chun;
Koeppen, Hartmut;
Cohn, Allen L.

Publication type:

Article